Facultade de Farmacia
Fakultät
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (17)
2024
-
Hypothalamic free fatty acid receptor-1 regulates whole-body energy balance
Molecular Metabolism, Vol. 79
2023
-
Astrocytic insulin receptor controls circadian behavior via dopamine signaling in a sexually dimorphic manner
Nature Communications, Vol. 14, Núm. 1
-
CPT1A in AgRP neurons is required for sex-dependent regulation of feeding and thirst
Biology of Sex Differences, Vol. 14, Núm. 1
2022
-
Olfactomedin 2 deficiency protects against diet-induced obesity
Metabolism: Clinical and Experimental, Vol. 129
2021
-
Potent and Subtype-Selective Dopamine D2Receptor Biased Partial Agonists Discovered via an Ugi-Based Approach
Journal of Medicinal Chemistry, Vol. 64, Núm. 12, pp. 8710-8726
-
Similarities and differences upon binding of naturally occurring Δ9-tetrahydrocannabinol-derivatives to cannabinoid CB1 and CB2 receptors
Pharmacological Research, Vol. 174
2020
-
Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6
Journal of Medicinal Chemistry, Vol. 63, Núm. 17, pp. 9360-9390
2019
-
Central nicotine induces browning through hypothalamic κ opioid receptor
Nature Communications, Vol. 10, Núm. 1
-
Hypothalamic dopamine signalling regulates brown fat thermogenesis
Nature Metabolism, Vol. 1, Núm. 8, pp. 811-829
-
New flavonoid–N,N-dibenzyl(N-methyl)amine hybrids: Multi-target-directed agents for Alzheimer´s disease endowed with neurogenic properties
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 712-727
2018
-
Genetic enhancement of Ras-ERK pathway does not aggravate L-DOPA-induced dyskinesia in mice but prevents the decrease induced by lovastatin
Scientific Reports, Vol. 8, Núm. 1
-
Neurogenic and neuroprotective donepezil-flavonoid hybrids with sigma-1 affinity and inhibition of key enzymes in Alzheimer's disease
European Journal of Medicinal Chemistry, Vol. 156, pp. 534-553
2017
-
Pharmacological tools based on imidazole scaffold proved the utility of PDE10A inhibitors for Parkinson's disease
Future Medicinal Chemistry, Vol. 9, Núm. 8, pp. 731-748
2016
-
New cinnamic - N-benzylpiperidine and cinnamic - N,N-dibenzyl(N-methyl)amine hybrids as Alzheimer-directed multitarget drugs with antioxidant, cholinergic, neuroprotective and neurogenic properties
European Journal of Medicinal Chemistry, Vol. 121, pp. 376-386
2014
-
Modulation of cAMP-specific PDE without emetogenic activity: New sulfide-like PDE7 inhibitors
Journal of Medicinal Chemistry, Vol. 57, Núm. 20, pp. 8590-8607
2012
-
Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds
Journal of Medicinal Chemistry, Vol. 55, Núm. 7, pp. 3274-3284
-
Guidelines for the use and interpretation of assays for monitoring autophagy
Autophagy, Vol. 8, Núm. 4, pp. 445-544